Exebenus AS – Trademark Portfolio
Entity Type: 61
Exebenus AS holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 4 filings in this category. The portfolio also extends into Class 37 (Building & Construction) across 4 Nice Classification classes. Currently, 4 trademarks are registered and 1 is pending. Notable registered marks include EXEBENUS, E EXEBENUS, EXEBENUS PULSE, and EXEBENUS SPOTTER. The owner is based in Stavanger.
Kanalsletta 2
Stavanger 4033 , NO
Showing of trademarks Trademarks
Trademark Classifications
Exebenus AS's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does Exebenus AS have?
Exebenus AS has 5 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 pending.
What trademark classes does Exebenus AS file in?
Exebenus AS files trademarks across 4 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 37 (Building & Construction), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Exebenus AS's most well-known trademarks?
Exebenus AS's registered trademark portfolio includes well-known marks such as EXEBENUS, E EXEBENUS, EXEBENUS PULSE, and EXEBENUS SPOTTER. These are among 4 currently registered trademarks in the portfolio.
What is Exebenus AS's trademark registration success rate?
Exebenus AS has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 1 application is pending review.